staggered application and synchronized removal [Design Issues]

posted by ClinResBE – India, 2014-10-03 17:38 (4287 d 09:52 ago) – Posting: # 13647
Views: 5,740

Hi Jo,

❝ The question is: how do I have to allocate the moment of application for the treated sites for one subject and / or for all subjects?


The sites will be randomized for both arms and dosing will be done for all subjects.

Please find the images that should clarify the order of treatment (staggered application & synchrovized removal) for dose duration response study and pivotal studies. This is as recommended by the guidance document 'GUIDANCE TOPICAL DERMATOLOGIC CORTICOSTEROIDS:IN VIVO BIOEQUIVALENCE'

[image]

[image]

I hope this will help you.

Max

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
305 visitors (0 registered, 305 guests [including 31 identified bots]).
Forum time: 03:31 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5